
Research Data Manager at @Gateshead_NHS, all views are my own. Check out the R&D Twitter @QEHResearch to see what we've been up to! 😊 #Research #ClinicalTrials
- Tweets80
- Following98
- Followers21
- Likes507

ALT The title of this infographic is "the INGRID2 trial is identifying babies at risk of type 1 diabetes". On the left, there are three facts: 20,000 babies recruited to date 11 hospitals running the trial. More sites to open in Jan 2025 309 babies identified as at risk of type 1 diabetes to date. On the left, there is feedback from people whose baby has taken part in the trial: “Felt like we were contributing to something important and also benefiting from it.” “The research staff was very understanding and helped with questions I may have had.” “Two researchers came to chat to me and gave me time to read on my own. The consent process was not rushed and was at a calm point when I wasn’t distracted with the baby.” Along the bottom, the text reads: We’re part of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD). The platform aims to establish an international infrastructure for studies dedicated to preventing the development of type 1 diabetes.
















